Halozyme Therapeutics Ownership 2024 | Who Owns Halozyme Therapeutics Now?
Institutional Ownership
94.57%
Insider Ownership
1.11%
Retail Ownership
4.31%
Institutional Holders
413.00
Halozyme Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 14.13% | 0.02% | 18,241,548 | -389,415 | -2.09% | 742,066,172 | Mar 31, 2024 |
| VANGUARD GROUP INC | 10.11% | 0.01% | 13,049,253 | -210,261 | -1.59% | 530,843,613 | Mar 31, 2024 |
| STATE STREET CORP | 5.03% | 0.01% | 6,487,303 | 11,754 | 0.18% | 263,903,486 | Mar 31, 2024 |
| SNYDER CAPITAL MANAGEMENT L P | 3.19% | 3.59% | 4,117,227 | 407,628 | 10.99% | 167,488,794 | Mar 31, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.94% | 0.22% | 3,791,230 | -2,897,828 | -43.32% | 154,227,236 | Mar 31, 2024 |
| ALLIANCEBERNSTEIN L.P. | 2.84% | 0.05% | 3,666,324 | 202,630 | 5.85% | 149,146,060 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 2.51% | 0.01% | 3,240,497 | 146,565 | 4.74% | 131,823,416 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.35% | 0.01% | 3,027,384 | 107,621 | 3.69% | 123,171,534 | Mar 31, 2024 |
| MACQUARIE GROUP LTD | 2.32% | 0.14% | 2,991,125 | -291,515 | -8.88% | 121,679,000 | Mar 31, 2024 |
| TD ASSET MANAGEMENT INC | 1.97% | 0.10% | 2,541,266 | 557,350 | 28.09% | 103,378,701 | Mar 31, 2024 |
| GW&K INVESTMENT MANAGEMENT, LLC | 1.70% | 0.79% | 2,196,877 | -29,661 | -1.33% | 89,369,000 | Mar 31, 2024 |
| INVESCO LTD. | 1.62% | 0.02% | 2,088,410 | 57,776 | 2.85% | 84,956,520 | Mar 31, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.44% | 0.85% | 1,858,841 | 282,758 | 17.94% | 75,617,652 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 1.39% | 0.01% | 1,791,904 | -181,840 | -9.21% | 72,894,654 | Mar 31, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 1.33% | 0.14% | 1,714,844 | -206,815 | -10.76% | 69,760,000 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.32% | 0.01% | 1,697,152 | 509,493 | 42.90% | 69,040,143,000 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.31% | 0.02% | 1,688,229 | 75,116 | 4.66% | 68,677,157 | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.29% | 0.02% | 1,667,479 | -68,643 | -3.95% | 67,833,046 | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.28% | 0.02% | 1,651,610 | 126,408 | 8.29% | 67,187,839 | Mar 31, 2024 |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 1.20% | 0.84% | 1,546,666 | 28,211 | 1.86% | 62,918,373 | Mar 31, 2024 |
Halozyme Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 14.13% of the company's total share outstanding, currently valued at $742.07M. The top 10 institutional shareholders own together 47.39% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FUTURE FUND LLC | 0.01% | 4.05% | 12,275 | 5,109 | 71.30% | 499,347 | Mar 31, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.20% | 4.00% | 255,049 | 14,601 | 6.07% | 10,375,393 | Mar 31, 2024 |
| SNYDER CAPITAL MANAGEMENT L P | 3.19% | 3.59% | 4,117,227 | 407,628 | 10.99% | 167,488,794 | Mar 31, 2024 |
| BERNZOTT CAPITAL ADVISORS | 0.16% | 3.38% | 209,804 | 84,825 | 67.87% | 8,534,827 | Mar 31, 2024 |
| KOA WEALTH MANAGEMENT, LLC | 0.06% | 2.73% | 74,416 | 9,503 | 14.64% | 3,027,243 | Mar 31, 2024 |
| 2XIDEAS AG | 0.40% | 2.57% | 515,462 | -28,704 | -5.27% | 20,968,994 | Mar 31, 2024 |
| STEAMBOAT CAPITAL PARTNERS, LLC | 0.13% | 2.41% | 171,949 | 2,865 | 1.69% | 6,994,885 | Mar 31, 2024 |
| HARVEY CAPITAL MANAGEMENT INC | 0.14% | 2.16% | 181,490 | 21,380 | 13.35% | 7,383,013 | Mar 31, 2024 |
| MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. | 0.28% | 1.32% | 364,047 | -89,780 | -19.78% | 14,809,432 | Mar 31, 2024 |
| GRANITE INVESTMENT PARTNERS, LLC | 0.63% | 1.26% | 811,458 | -20,964 | -2.52% | 33,010,111 | Mar 31, 2024 |
| PIER CAPITAL, LLC | 0.17% | 1.25% | 222,632 | 93,153 | 71.94% | 9,056,670 | Mar 31, 2024 |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 0.21% | 0.99% | 272,596 | -6,944 | -2.48% | 11,130,236 | Mar 31, 2024 |
| ELEQUIN SECURITIES, LLC | 0.21% | 0.99% | 272,596 | 272,596 | 100.00% | 11,130,236 | Mar 31, 2024 |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | 0.11% | 0.98% | 140,089 | 9,357 | 7.16% | 5,693,217 | Mar 31, 2024 |
| SHAKER INVESTMENTS LLC/OH | 0.04% | 0.91% | 52,683 | 115 | 0.22% | 2,143,144 | Mar 31, 2024 |
| REDWOOD INVESTMENTS, LLC | 0.06% | 0.91% | 77,306 | -15,744 | -16.92% | 3,100,101 | Mar 31, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.10% | 0.86% | 123,924 | 123,924 | 100.00% | 5,041,228 | Mar 31, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.44% | 0.85% | 1,858,841 | 282,758 | 17.94% | 75,617,652 | Mar 31, 2024 |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 1.20% | 0.84% | 1,546,666 | 28,211 | 1.86% | 62,918,373 | Mar 31, 2024 |
| HODGES CAPITAL MANAGEMENT INC. | 0.25% | 0.82% | 317,045 | 120,580 | 61.37% | 12,897 | Mar 31, 2024 |
The largest Halozyme Therapeutics shareholder by % of total assets is FUTURE FUND LLC. The company owns 12.28K shares of Halozyme Therapeutics (HALO), representing 4.05% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FIRST TRUST ADVISORS LP | 0.93% | 0.05% | 1,194,464 | 1,102,623 | 1200.58% | 48,590,795 | Mar 31, 2024 |
| HANDELSBANKEN FONDER AB | 0.64% | 0.15% | 828,669 | 582,600 | 236.76% | 33,710,000 | Mar 31, 2024 |
| TD ASSET MANAGEMENT INC | 1.97% | 0.10% | 2,541,266 | 557,350 | 28.09% | 103,378,701 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.32% | 0.01% | 1,697,152 | 509,493 | 42.90% | 69,040,143,000 | Mar 31, 2024 |
| SNYDER CAPITAL MANAGEMENT L P | 3.19% | 3.59% | 4,117,227 | 407,628 | 10.99% | 167,488,794 | Mar 31, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.31% | 0.06% | 398,306 | 343,572 | 627.71% | 16,203,088 | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.31% | 0.03% | 395,420 | 298,985 | 310.04% | 16,085,686 | Mar 31, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.44% | 0.85% | 1,858,841 | 282,758 | 17.94% | 75,617,652 | Mar 31, 2024 |
| ELEQUIN SECURITIES, LLC | 0.21% | 0.99% | 272,596 | 272,596 | 100.00% | 11,130,236 | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | 0.23% | 0.01% | 298,125 | 272,549 | 1065.64% | 12,127,725 | Mar 31, 2024 |
| EPOCH INVESTMENT PARTNERS, INC. | 1.11% | 0.26% | 1,433,612 | 270,579 | 23.26% | 58,319,336 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.33% | 0.03% | 431,380 | 238,000 | 123.07% | 17,549,000 | Mar 31, 2024 |
| FRANKLIN RESOURCES INC | 0.24% | 0.00% | 307,704 | 233,909 | 316.97% | 12,517,400 | Mar 31, 2024 |
| ALLIANCEBERNSTEIN L.P. | 2.84% | 0.05% | 3,666,324 | 202,630 | 5.85% | 149,146,060 | Mar 31, 2024 |
| LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA | 0.14% | 0.50% | 175,000 | 175,000 | 100.00% | 7,119,000 | Mar 31, 2024 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 0.44% | 0.10% | 568,361 | 158,679 | 38.73% | 23,120,908,000 | Mar 31, 2024 |
| WINTON GROUP LTD | 0.11% | 0.43% | 148,130 | 148,130 | 100.00% | 6,025,928 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.25% | 0.07% | 319,296 | 146,817 | 85.12% | 12,988,971 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 2.51% | 0.01% | 3,240,497 | 146,565 | 4.74% | 131,823,416 | Mar 31, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.28% | 0.02% | 1,651,610 | 126,408 | 8.29% | 67,187,839 | Mar 31, 2024 |
As of Mar 31 2024, Halozyme Therapeutics's largest institutional buyer is FIRST TRUST ADVISORS LP. The company purchased 1.10M stocks of HALO, valued at $48.59M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 2.94% | 0.22% | 3,791,230 | -2,897,828 | -43.32% | 154,227,236 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.64% | 0.01% | 821,386 | -720,224 | -46.72% | 33,413,982 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.06% | 0.00% | 75,533 | -570,635 | -88.31% | 3,072,683 | Mar 31, 2024 |
| BLACKROCK INC. | 14.13% | 0.02% | 18,241,548 | -389,415 | -2.09% | 742,066,172 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -331,703 | -100.00% | - | Mar 31, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.03% | 0.00% | 42,668 | -295,932 | -87.40% | 1,735,734 | Mar 31, 2024 |
| MACQUARIE GROUP LTD | 2.32% | 0.14% | 2,991,125 | -291,515 | -8.88% | 121,679,000 | Mar 31, 2024 |
| EAGLE ASSET MANAGEMENT INC | - | - | - | -232,113 | -100.00% | - | Mar 31, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -222,279 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | 10.11% | 0.01% | 13,049,253 | -210,261 | -1.59% | 530,843,613 | Mar 31, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 1.33% | 0.14% | 1,714,844 | -206,815 | -10.76% | 69,760,000 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 1.39% | 0.01% | 1,791,904 | -181,840 | -9.21% | 72,894,654 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.10% | 0.00% | 132,068 | -178,838 | -57.52% | 5,372,526 | Mar 31, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -173,808 | -100.00% | - | Mar 31, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -159,242 | -100.00% | - | Mar 31, 2024 |
| SEI INVESTMENTS CO | 0.26% | 0.02% | 329,123 | -151,673 | -31.55% | 13,388,674 | Mar 31, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.40% | 0.43% | 513,096 | -149,720 | -22.59% | 20,872,745 | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | - | - | - | -134,050 | -100.00% | - | Mar 31, 2024 |
| BARCLAYS PLC | 0.22% | 0.00% | 284,579 | -126,119 | -30.71% | 11,576,000 | Mar 31, 2024 |
| BAIRD FINANCIAL GROUP, INC. | 0.01% | 0.00% | 11,083 | -116,715 | -91.33% | 450,856 | Mar 31, 2024 |
As of Mar 31 2024, Halozyme Therapeutics's biggest institutional seller is ARTISAN PARTNERS LIMITED PARTNERSHIP. The company sold -2.90M shares of HALO, valued at $154.23M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ELEQUIN SECURITIES, LLC | 0.21% | 0.99% | 272,596 | 272,596 | 100.00% | 11,130,236 | Mar 31, 2024 |
| LOMBARD ODIER ASSET MANAGEMENT (SWITZERLAND) SA | 0.14% | 0.50% | 175,000 | 175,000 | 100.00% | 7,119,000 | Mar 31, 2024 |
| WINTON GROUP LTD | 0.11% | 0.43% | 148,130 | 148,130 | 100.00% | 6,025,928 | Mar 31, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.10% | 0.86% | 123,924 | 123,924 | 100.00% | 5,041,228 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.09% | 0.01% | 113,792 | 113,792 | 100.00% | 4,629,059 | Mar 31, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 0.09% | 0.36% | 112,900 | 112,900 | 100.00% | 4,592,772 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.07% | 0.00% | 91,200 | 91,200 | 100.00% | 3,710,016 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05% | 0.00% | 60,833 | 60,833 | 100.00% | 2,474,686 | Mar 31, 2024 |
| TORNO CAPITAL, LLC | 0.04% | 0.13% | 50,000 | 50,000 | 100.00% | 2,034,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.04% | 0.00% | 46,700 | 46,700 | 100.00% | 1,899,756 | Mar 31, 2024 |
| ADVISORS PREFERRED, LLC | 0.02% | 0.17% | 24,847 | 24,847 | 100.00% | 1,026,678 | Mar 31, 2024 |
| TECTONIC ADVISORS LLC | 0.01% | 0.06% | 18,241 | 18,241 | 100.00% | 742,044 | Mar 31, 2024 |
| SHELTON WEALTH MANAGEMENT, LLC | 0.01% | 0.46% | 18,040 | 18,040 | 100.00% | 733,867 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.01% | 0.00% | 15,172 | 15,172 | 100.00% | 617,000 | Mar 31, 2024 |
| PATHSTONE HOLDINGS, LLC | 0.01% | 0.00% | 13,561 | 13,561 | 100.00% | 551,661 | Mar 31, 2024 |
| OAK HILL WEALTH ADVISORS, LLC | 0.01% | 0.15% | 11,300 | 11,300 | 100.00% | 459,684 | Mar 31, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.01% | 0.01% | 11,042 | 11,042 | 100.00% | 449,189 | Mar 31, 2024 |
| UNIQUE WEALTH STRATEGIES, LLC | 0.01% | 0.22% | 10,943 | 10,943 | 100.00% | 445,162 | Mar 31, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | 0.01% | 0.00% | 10,559 | 10,559 | 100.00% | 429,540 | Mar 31, 2024 |
| DIVERSIFY ADVISORY SERVICES, LLC | 0.01% | 0.02% | 8,331 | 8,331 | 100.00% | 344,237 | Mar 31, 2024 |
| SCIENTECH RESEARCH LLC | 0.01% | 0.18% | 8,214 | 8,214 | 100.00% | 334,146 | Mar 31, 2024 |
| 0.01% | 0.01% | 8,045 | 8,045 | 100.00% | 327,276 | Mar 31, 2024 | |
| ZUCKERMAN INVESTMENT GROUP, LLC | 0.01% | 0.04% | 8,000 | 8,000 | 100.00% | 325,440 | Mar 31, 2024 |
| WRAPMANAGER INC | 0.01% | 0.09% | 7,949 | 7,949 | 100.00% | 323,365 | Mar 31, 2024 |
| JUNCTURE WEALTH STRATEGIES, LLC | 0.01% | 0.13% | 7,459 | 7,459 | 100.00% | 303,432 | Mar 31, 2024 |
| STIFEL FINANCIAL CORP | 0.01% | 0.00% | 7,133 | 7,133 | 100.00% | 290,173 | Mar 31, 2024 |
| ALPHA DNA INVESTMENT MANAGEMENT LLC | 0.01% | 0.10% | 6,676 | 6,676 | 100.00% | 271,579 | Mar 31, 2024 |
| TWIN TREE MANAGEMENT, LP | 0.01% | 0.00% | 6,600 | 6,600 | 100.00% | 268,488 | Mar 31, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.01% | 0.07% | 6,590 | 6,590 | 100.00% | 268,066 | Mar 31, 2024 |
| BALBOA WEALTH PARTNERS | 0.00% | 0.07% | 5,768 | 5,768 | 100.00% | 234,642 | Mar 31, 2024 |
| SHEAFF BROCK INVESTMENT ADVISORS, LLC | 0.00% | 0.01% | 5,540 | 5,540 | 100.00% | 225,368 | Mar 31, 2024 |
| RESOURCES INVESTMENT ADVISORS, LLC. | 0.00% | 0.00% | 5,478 | 5,478 | 100.00% | 222,845 | Mar 31, 2024 |
| MML INVESTORS SERVICES, LLC | 0.00% | 0.00% | 5,437 | 5,437 | 100.00% | 221,000 | Mar 31, 2024 |
| OLD NATIONAL BANCORP /IN/ | 0.00% | 0.01% | 5,207 | 5,207 | 100.00% | 211,820 | Mar 31, 2024 |
| CALLAN CAPITAL, LLC | 0.00% | 0.02% | 5,128 | 5,128 | 100.00% | 208,607 | Mar 31, 2024 |
| TITLEIST ASSET MANAGEMENT, LLC | 0.00% | 0.04% | 5,014 | 5,014 | 100.00% | 203,970 | Mar 31, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | 0.00% | 2,883 | 2,883 | 100.00% | 119,126,000 | Mar 31, 2024 |
| CENTRAL PACIFIC BANK - TRUST DIVISION | 0.00% | 0.01% | 2,820 | 2,820 | 100.00% | 116,522 | Mar 31, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.18% | 1,800 | 1,800 | 100.00% | 73,224,000 | Mar 31, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | 0.00% | 0.04% | 1,284 | 1,284 | 100.00% | 334,490 | Mar 31, 2024 |
| WHITTIER TRUST CO | 0.00% | 0.00% | 672 | 672 | 100.00% | 27,336 | Mar 31, 2024 |
| RISE ADVISORS, LLC | 0.00% | 0.01% | 611 | 611 | 100.00% | 24,855 | Mar 31, 2024 |
| MATHER GROUP, LLC. | 0.00% | 0.00% | 205 | 205 | 100.00% | 7,577,000 | Mar 31, 2024 |
| DAVIDSON CAPITAL MANAGEMENT INC. | 0.00% | 0.00% | 184 | 184 | 100.00% | 7,486 | Mar 31, 2024 |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 0.00% | 0.00% | 85 | 85 | 100.00% | 3,458 | Mar 31, 2024 |
| CONTINUUM ADVISORY, LLC | 0.00% | 0.00% | 71 | 71 | 100.00% | 3,113,000 | Mar 31, 2024 |
| VITALSTONE FINANCIAL, LLC | 0.00% | 0.00% | 67 | 67 | 100.00% | 3 | Mar 31, 2024 |
| - | 0.00% | 42 | 42 | 100.00% | 1,832 | Mar 31, 2024 | |
| UMB BANK, N.A. | - | - | 38 | 38 | 100.00% | 1,546 | Mar 31, 2024 |
| VALLEY NATIONAL ADVISERS INC | - | 0.00% | 35 | 35 | 100.00% | 1,000 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 26 | 26 | 100.00% | 1,057 | Mar 31, 2024 |
| CAROLINAS WEALTH CONSULTING LLC | - | 0.00% | 22 | 22 | 100.00% | 913 | Mar 31, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | - | 0.00% | 16 | 16 | 100.00% | 371,000 | Mar 31, 2024 |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | - | 0.00% | 10 | 10 | 100.00% | 407 | Mar 31, 2024 |
Halozyme Therapeutics's largest new institutional shareholder by number of shares is ELEQUIN SECURITIES, LLC, purchased 272.60K shares, valued at $11.13M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -331,703 | -100.00% | - | Mar 31, 2024 |
| EAGLE ASSET MANAGEMENT INC | - | - | - | -232,113 | -100.00% | - | Mar 31, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -222,279 | -100.00% | - | Mar 31, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -173,808 | -100.00% | - | Mar 31, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -159,242 | -100.00% | - | Mar 31, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | - | - | - | -134,050 | -100.00% | - | Mar 31, 2024 |
| CASTLEARK MANAGEMENT LLC | - | - | - | -115,894 | -100.00% | - | Mar 31, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -105,000 | -100.00% | - | Mar 31, 2024 |
| OBERWEIS ASSET MANAGEMENT INC/ | - | - | - | -96,300 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -78,318 | -100.00% | - | Mar 31, 2024 |
| POINT72 HONG KONG LTD | - | - | - | -56,675 | -100.00% | - | Mar 31, 2024 |
| COWEN AND COMPANY, LLC | - | - | - | -54,034 | -100.00% | - | Mar 31, 2024 |
| EVOKE WEALTH, LLC | - | - | - | -36,657 | -100.00% | - | Mar 31, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -34,502 | -100.00% | - | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -31,500 | -100.00% | - | Mar 31, 2024 |
| HIGHMARK WEALTH MANAGEMENT LLC | - | - | - | -31,290 | -100.00% | - | Mar 31, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | - | - | - | -27,868 | -100.00% | - | Mar 31, 2024 |
| DOHENY ASSET MANAGEMENT /CA | - | - | - | -22,578 | -100.00% | - | Mar 31, 2024 |
| SIT INVESTMENT ASSOCIATES INC | - | - | - | -20,225 | -100.00% | - | Mar 31, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -19,422 | -100.00% | - | Mar 31, 2024 |
| WOLVERINE ASSET MANAGEMENT LLC | - | - | - | -17,500 | -100.00% | - | Mar 31, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -16,504 | -100.00% | - | Mar 31, 2024 |
| FIRST WESTERN TRUST BANK | - | - | - | -15,616 | -100.00% | - | Mar 31, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | - | - | - | -14,700 | -100.00% | - | Mar 31, 2024 |
| OAK HILL WEALTH ADVISORS, LLC | - | - | - | -12,500 | -100.00% | - | Mar 31, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -11,725 | -100.00% | - | Mar 31, 2024 |
| INSPIRE INVESTING, LLC | - | - | - | -10,370 | -100.00% | - | Mar 31, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -9,294 | -100.00% | - | Mar 31, 2024 |
| AFFINITY INVESTMENT ADVISORS, LLC | - | - | - | -8,886 | -100.00% | - | Mar 31, 2024 |
| HOYLECOHEN, LLC | - | - | - | -8,775 | -100.00% | - | Mar 31, 2024 |
| AE WEALTH MANAGEMENT LLC | - | - | - | -8,372 | -100.00% | - | Mar 31, 2024 |
| CAXTON ASSOCIATES LP | - | - | - | -8,281 | -100.00% | - | Mar 31, 2024 |
| CONVERGENCE INVESTMENT PARTNERS, LLC | - | - | - | -7,008 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -6,500 | -100.00% | - | Mar 31, 2024 |
| EFG ASSET MANAGEMENT (AMERICAS) CORP. | - | - | - | -6,496 | -100.00% | - | Mar 31, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | - | - | - | -6,380 | -100.00% | - | Mar 31, 2024 |
| IFRAH FINANCIAL SERVICES, INC. | - | - | - | -6,060 | -100.00% | - | Mar 31, 2024 |
| CIPHER CAPITAL LP | - | - | - | -5,904 | -100.00% | - | Mar 31, 2024 |
| EP WEALTH ADVISORS, LLC | - | - | - | -5,500 | -100.00% | - | Mar 31, 2024 |
| KAPITALO INVESTIMENTOS LTDA | - | - | - | -3,593 | -100.00% | - | Mar 31, 2024 |
| WALLEYE TRADING LLC | - | - | - | -3,000 | -100.00% | - | Mar 31, 2024 |
| HEADLANDS TECHNOLOGIES LLC | - | - | - | -1,764 | -100.00% | - | Mar 31, 2024 |
| JOHNSON FINANCIAL GROUP, INC. | - | - | - | -532 | -100.00% | - | Mar 31, 2024 |
| ADVISORY SERVICES NETWORK, LLC | - | - | - | -529 | -100.00% | - | Mar 31, 2024 |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | - | - | - | -436 | -100.00% | - | Mar 31, 2024 |
| SILICON VALLEY CAPITAL PARTNERS | - | - | - | -300 | -100.00% | - | Mar 31, 2024 |
| POINT72 EUROPE (LONDON) LLP | - | - | - | -261 | -100.00% | - | Mar 31, 2024 |
| TURTLE CREEK WEALTH ADVISORS, LLC | - | - | - | -211 | -100.00% | - | Mar 31, 2024 |
| GLASSMAN WEALTH SERVICES | - | - | - | -68 | -100.00% | - | Mar 31, 2024 |
| M&R CAPITAL MANAGEMENT INC | - | - | - | -32 | -100.00% | - | Mar 31, 2024 |
| RFP FINANCIAL GROUP LLC | - | - | - | -31 | -100.00% | - | Mar 31, 2024 |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | - | - | - | -15 | -100.00% | - | Mar 31, 2024 |
| ROSENBERG MATTHEW HAMILTON | - | - | - | -1 | -100.00% | - | Mar 31, 2024 |
Halozyme Therapeutics's largest sold out institutional shareholder by shares sold is DRIEHAUS CAPITAL MANAGEMENT LLC, sold -0.33M shares, valued at -, as of undefined.
Halozyme Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| AMG FUNDS | 3.38% | 376,774 | - | - | Jan 31, 2024 |
| SPARROW FUNDS | 2.34% | 8,340 | - | - | Feb 29, 2024 |
| BANCROFT FUND LTD | 2.31% | 3,200,000 | 1,000,000 | 45.45% | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 2.14% | 3,000,000 | 700,000 | 30.43% | Dec 29, 2023 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 1.89% | 1,500,000 | 200,000 | 15.38% | Dec 29, 2023 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 1.64% | 1,300,000 | - | - | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 1.64% | 2,300,000 | - | - | Dec 29, 2023 |
| BANCROFT FUND LTD | 1.59% | 2,200,000 | - | - | Dec 29, 2023 |
| Virtus Diversified Income & Convertible Fund | 1.27% | 2,590,000 | - | - | Jan 31, 2024 |
| Fiera Capital Series Trust | 1.25% | 24,956 | - | - | Jun 30, 2023 |
| Virtus Dividend, Interest & Premium Strategy Fund | 1.20% | 2,845,000 | - | - | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 1.20% | 2,845,000 | - | - | Jan 31, 2024 |
| Virtus Equity & Convertible Income Fund | 1.18% | 2,330,000 | - | - | Jan 31, 2024 |
| Virtus Equity & Convertible Income Fund | 1.18% | 2,330,000 | - | - | Jan 31, 2024 |
| Calamos Dynamic Convertible & Income Fund | 1.05% | 8,000,000 | - | - | Jan 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.99% | 2,020,000 | - | - | Jan 31, 2024 |
| Virtus Strategy Trust | 0.96% | 21,070,000 | - | - | Dec 29, 2023 |
| Virtus Strategy Trust | 0.87% | 19,150,000 | - | - | Dec 29, 2023 |
| AGF Investments Trust | 0.86% | -30,627 | - | - | Dec 31, 2023 |
| CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | 0.81% | 9,250,000 | - | - | Jan 31, 2024 |
| CALAMOS CONVERTIBLE & HIGH INCOME FUND | 0.80% | 10,000,000 | - | - | Jan 31, 2024 |
| TETON WESTWOOD FUNDS | 0.77% | 500,000 | 100,000 | 25.00% | Dec 29, 2023 |
| CALAMOS ADVISORS TRUST/IL | 0.65% | 44,000 | - | - | Dec 31, 2023 |
| CALAMOS ADVISORS TRUST/IL | 0.65% | 44,000 | - | - | Dec 31, 2023 |
| TETON WESTWOOD FUNDS | 0.62% | 400,000 | - | - | Dec 29, 2023 |
| Thrivent ETF Trust | 0.50% | 24,793 | - | - | Dec 31, 2023 |
| Gabelli Healthcare & WellnessRx Trust | 0.50% | 60,000 | 8,081 | 15.56% | Dec 29, 2023 |
| Virtus Convertible & Income Fund | 0.49% | 2,435,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.49% | 2,435,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund II | 0.49% | 1,835,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund II | 0.49% | 1,835,000 | - | - | Jan 31, 2024 |
| Virtus Investment Trust | 0.48% | 16,420,000 | - | - | Dec 29, 2023 |
| Virtus Investment Trust | 0.47% | 16,055,000 | - | - | Dec 29, 2023 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.45% | 1,065,000 | - | - | Jan 31, 2024 |
| Virtus Equity & Convertible Income Fund | 0.45% | 885,000 | - | - | Jan 31, 2024 |
| Federated Hermes Equity Income Fund, Inc. | 0.44% | 65,350 | - | - | Feb 29, 2024 |
| CALAMOS STRATEGIC TOTAL RETURN FUND | 0.40% | 4,435,000 | - | - | Jan 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.38% | 780,000 | - | - | Jan 31, 2024 |
| Virtus Strategy Trust | 0.36% | 7,865,000 | - | - | Dec 29, 2023 |
| BlackRock Innovation & Growth Trust | 0.35% | 410,430 | -124,434 | -23.26% | Dec 31, 2023 |
| CALAMOS INVESTMENT TRUST/IL | 0.34% | 35,075,000 | - | - | Jan 31, 2024 |
| HSBC FUNDS | 0.33% | 10,710 | - | - | Jan 31, 2024 |
| Clough Global Equity Fund | 0.29% | 18,100 | - | - | Jan 31, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.29% | 431,392 | -5,185 | -1.19% | Jan 31, 2024 |
| SPDR S&P MIDCAP 400 ETF TRUST | 0.28% | 1,070,908 | -10,074 | -0.93% | Dec 29, 2023 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.28% | 1,009,700 | -118,800 | -10.53% | Dec 31, 2023 |
| Virtus Strategy Trust | 0.27% | 6,005,000 | - | - | Dec 29, 2023 |
| Virtus Convertible & Income Fund II | 0.26% | 970,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.25% | 1,230,000 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.24% | 254,258 | -17,236 | -6.35% | Dec 29, 2023 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.23% | 211,900 | - | - | Jan 31, 2024 |
| BUFFALO FUNDS | 0.22% | 472,134 | 23,210 | 5.17% | Dec 31, 2023 |
| BNY MELLON MIDCAP INDEX FUND, INC. | 0.19% | 81,684 | -5,219 | -6.01% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.19% | 92,464 | - | - | Dec 31, 2023 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.18% | 33,677 | 2,345 | 7.48% | Dec 29, 2023 |
| Federated Hermes MDT Series | 0.17% | 429,908 | 286,345 | 199.46% | Jan 31, 2024 |
| CALAMOS GLOBAL TOTAL RETURN FUND | 0.16% | 375,000 | - | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.16% | 38,589 | - | - | Dec 31, 2023 |
| Calamos Global Dynamic Income Fund | 0.13% | 1,550,000 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.13% | 1,596,524 | 143,486 | 9.87% | Jan 31, 2024 |
| OBERWEIS FUNDS | 0.12% | 96,300 | 45,800 | 90.69% | Dec 31, 2023 |
| NUVEEN INVESTMENT TRUST | 0.09% | 34,984 | -693 | -1.94% | Dec 31, 2023 |
| MERIDIAN FUND INC | 0.08% | 297,134 | - | - | Dec 29, 2023 |
| Clough Global Opportunities Fund | 0.08% | 32,900 | - | - | Jan 31, 2024 |
| M FUND INC | 0.08% | 37,596 | 10,149 | 36.98% | Mar 31, 2024 |
| AMG FUNDS III | 0.08% | 12,423 | - | - | Feb 29, 2024 |
| Federated Hermes Index Trust | 0.07% | 16,237 | -656 | -3.88% | Jan 31, 2024 |
| ALGER FUNDS | 0.07% | 69,352 | - | - | Jan 31, 2024 |
| Total Fund Solution | 0.07% | 24,213 | - | - | Dec 31, 2023 |
| Voya VARIABLE PRODUCTS TRUST | 0.07% | 19,912 | -364 | -1.80% | Dec 31, 2023 |
| VANGUARD ADMIRAL FUNDS | 0.06% | 269,191 | -2,158 | -0.80% | Feb 29, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.06% | 597,262 | 40,370 | 7.25% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.06% | 53,586 | -3,178 | -5.60% | Dec 31, 2023 |
| Voya PARTNERS INC | 0.06% | 4,845,000 | - | - | Dec 31, 2023 |
| Voya EQUITY TRUST | 0.06% | 85,325 | 4,781 | 5.94% | Feb 29, 2024 |
| BlackRock Health Sciences Trust II | 0.06% | 158,300 | - | - | Dec 31, 2023 |
| SYNTAX ETF TRUST | 0.06% | 1,800 | -35 | -1.91% | Dec 31, 2023 |
| ALLSPRING VARIABLE TRUST | 0.05% | 28,900 | -500 | -1.70% | Dec 31, 2023 |
| Gabelli Global Small & Mid Cap Value Trust | 0.05% | 5,000 | - | - | Dec 29, 2023 |
| BlackRock Health Sciences Trust | 0.05% | 21,055 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.04% | 19,782 | 341 | 1.75% | Dec 31, 2023 |
| REYNOLDS FUNDS INC | 0.04% | 500 | - | - | Mar 31, 2024 |
| SIT MUTUAL FUNDS INC | 0.04% | 14,375 | -17,300 | -54.62% | Dec 29, 2023 |
| TEKLA HEALTHCARE INVESTORS | 0.04% | 48,143 | - | - | Dec 31, 2023 |
| GABELLI ASSET FUND | 0.04% | 15,000 | - | - | Dec 29, 2023 |
| DSS AMERICAFIRST QUANTITATIVE FUNDS | 0.04% | 908 | - | - | Dec 29, 2023 |
| Humankind Benefit Corp | 0.04% | 857 | 68 | 8.62% | Dec 31, 2023 |
| TEKLA LIFE SCIENCES INVESTORS | 0.04% | 21,774 | - | - | Dec 31, 2023 |
| VIRTUS ALTERNATIVE SOLUTIONS TRUST | 0.04% | 147 | - | - | Jan 31, 2024 |
| TrimTabs ETF Trust | 0.04% | 23,766 | 16,919 | 247.10% | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.04% | 236,458 | 16,248 | 7.38% | Dec 31, 2023 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.04% | 17,640 | - | - | Dec 31, 2023 |
| GLENMEDE FUND INC | 0.03% | 303,653 | -8,640 | -2.77% | Jan 31, 2024 |
| Nuveen S&P 500 Dynamic Overwrite Fund | 0.03% | 1,972 | - | - | Dec 31, 2023 |
| Capitol Series Trust | 0.03% | 311,050 | 138,200 | 79.95% | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS V | 0.03% | 1,809,631 | -7,351 | -0.40% | Feb 29, 2024 |
| AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.03% | 1,000,000 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.03% | 13,283,810 | 2,057,558 | 18.33% | Dec 31, 2023 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.03% | 15,848 | - | - | Feb 29, 2024 |
| ROYCE VALUE TRUST, INC. | 0.02% | 29,353 | 29,353 | - | Dec 31, 2023 |
Halozyme Therapeutics's largest mutual fund holder by % of total assets is "AMG FUNDS", owning 376.77K shares, compromising 3.38% of its total assets.
Halozyme Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 413 | -0.96% |
| 31 Dec, 23 | 417 | 5.30% |
| 30 Sep, 23 | 396 | 5.04% |
| 30 Jun, 23 | 377 | -2.58% |
| 31 Mar, 23 | 387 | -10.83% |
| 31 Dec, 22 | 434 | 22.60% |
| 30 Sep, 22 | 354 | -3.80% |
| 30 Jun, 22 | 368 | 16.09% |
| 31 Mar, 22 | 317 | -3.06% |
| 31 Dec, 21 | 327 | 1.24% |
| 30 Sep, 21 | 323 | 1.25% |
| 30 Jun, 21 | 319 | -6.45% |
| 31 Mar, 21 | 341 | -0.87% |
| 31 Dec, 20 | 344 | 22.86% |
| 30 Sep, 20 | 280 | 1.82% |
| 30 Jun, 20 | 275 | 25.57% |
| 31 Mar, 20 | 219 | -7.20% |
| 31 Dec, 19 | 236 | 3.96% |
| 30 Sep, 19 | 227 | 5.58% |
| 30 Jun, 19 | 215 | 2.87% |
| 31 Mar, 19 | 209 | 3.98% |
| 31 Dec, 18 | 201 | 0.50% |
| 30 Sep, 18 | 200 | -1.96% |
| 30 Jun, 18 | 204 | -8.52% |
| 31 Mar, 18 | 223 | 4.69% |
| 31 Dec, 17 | 213 | 18.99% |
| 30 Sep, 17 | 179 | -1.65% |
| 30 Jun, 17 | 182 | 3.41% |
| 31 Mar, 17 | 176 | -3.83% |
| 31 Dec, 16 | 183 | 6.40% |
| 30 Sep, 16 | 172 | -1.15% |
| 30 Jun, 16 | 174 | -0.57% |
| 31 Mar, 16 | 175 | -0.57% |
| 31 Dec, 15 | 176 | -5.38% |
| 30 Sep, 15 | 186 | 10.06% |
| 30 Jun, 15 | 169 | 19.01% |
| 31 Mar, 15 | 142 | 1.43% |
| 31 Dec, 14 | 140 | 10.24% |
| 30 Sep, 14 | 127 | -7.30% |
| 30 Jun, 14 | 137 | -2.84% |
| 31 Mar, 14 | 141 | 10.16% |
| 31 Dec, 13 | 128 | 11.30% |
| 30 Sep, 13 | 115 | 2.68% |
| 30 Jun, 13 | 112 | 107.41% |
| 31 Mar, 13 | 54 | 5.88% |
| 31 Dec, 12 | 51 | 8.51% |
| 30 Sep, 12 | 47 | -9.62% |
| 30 Jun, 12 | 52 | -8.77% |
| 31 Mar, 12 | 57 | 5.56% |
| 31 Dec, 11 | 54 | 31.71% |
| 30 Sep, 11 | 41 | 10.81% |
| 30 Jun, 11 | 37 | -5.13% |
| 31 Mar, 11 | 39 | 11.43% |
| 31 Dec, 10 | 35 | 9.38% |
| 30 Sep, 10 | 32 | 6.67% |
| 30 Jun, 10 | 30 | 7.14% |
| 31 Mar, 10 | 28 | -3.45% |
| 31 Dec, 09 | 29 | 52.63% |
| 30 Sep, 09 | 19 | -26.92% |
| 30 Jun, 09 | 26 | 44.44% |
| 31 Mar, 09 | 18 | -25.00% |
| 31 Dec, 08 | 24 | 14.29% |
| 30 Sep, 08 | 21 | 31.25% |
| 30 Jun, 08 | 16 | 6.67% |
| 31 Mar, 08 | 15 | -11.76% |
| 31 Dec, 07 | 17 | - |
| 30 Sep, 07 | 17 | -5.56% |
| 30 Jun, 07 | 18 | 63.64% |
| 31 Mar, 07 | 11 | 57.14% |
| 31 Dec, 06 | 7 | 16.67% |
| 30 Sep, 06 | 6 | - |
| 30 Jun, 06 | 6 | - |
| 31 Mar, 06 | 6 | 100.00% |
| 31 Dec, 05 | 3 | - |
| 30 Sep, 05 | 3 | - |
| 30 Jun, 05 | 3 | - |
| 31 Mar, 05 | 3 | 50.00% |
| 31 Dec, 04 | 2 | - |
As of 31 Mar 24, 413 institutions are holding Halozyme Therapeutics's shares, representing a decrease of -0.96% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 122,049,630 | -1.69% |
| 31 Dec, 23 | 124,144,499 | 2.24% |
| 30 Sep, 23 | 121,421,868 | -0.34% |
| 30 Jun, 23 | 121,836,738 | -1.41% |
| 31 Mar, 23 | 123,575,162 | -3.90% |
| 31 Dec, 22 | 128,590,575 | -1.66% |
| 30 Sep, 22 | 130,764,721 | 3.03% |
| 30 Jun, 22 | 126,920,661 | 0.52% |
| 31 Mar, 22 | 126,259,874 | -0.86% |
| 31 Dec, 21 | 127,358,350 | -0.83% |
| 30 Sep, 21 | 128,425,909 | -0.18% |
| 30 Jun, 21 | 128,660,532 | -2.06% |
| 31 Mar, 21 | 131,362,215 | -3.56% |
| 31 Dec, 20 | 136,209,225 | 1.79% |
| 30 Sep, 20 | 133,814,748 | -0.90% |
| 30 Jun, 20 | 135,034,640 | 3.44% |
| 31 Mar, 20 | 130,539,846 | 2.56% |
| 31 Dec, 19 | 127,282,794 | 0.81% |
| 30 Sep, 19 | 126,253,902 | 3.23% |
| 30 Jun, 19 | 122,308,271 | 1.11% |
| 31 Mar, 19 | 120,966,485 | 0.10% |
| 31 Dec, 18 | 120,846,652 | -1.62% |
| 30 Sep, 18 | 122,836,446 | 0.37% |
| 30 Jun, 18 | 122,382,772 | -0.72% |
| 31 Mar, 18 | 123,274,827 | 0.96% |
| 31 Dec, 17 | 122,106,973 | 0.53% |
| 30 Sep, 17 | 121,459,384 | -0.41% |
| 30 Jun, 17 | 121,957,325 | 5.85% |
| 31 Mar, 17 | 115,211,787 | 4.11% |
| 31 Dec, 16 | 110,665,110 | 4.41% |
| 30 Sep, 16 | 105,987,871 | 0.87% |
| 30 Jun, 16 | 105,077,263 | 2.37% |
| 31 Mar, 16 | 102,644,695 | 4.35% |
| 31 Dec, 15 | 98,368,871 | -7.69% |
| 30 Sep, 15 | 106,566,697 | 9.42% |
| 30 Jun, 15 | 97,395,046 | 3.46% |
| 31 Mar, 15 | 94,136,666 | 3.05% |
| 31 Dec, 14 | 91,347,642 | 2.74% |
| 30 Sep, 14 | 88,909,692 | 3.86% |
| 30 Jun, 14 | 85,607,980 | -0.17% |
| 31 Mar, 14 | 85,756,477 | 8.43% |
| 31 Dec, 13 | 79,089,063 | 1.72% |
| 30 Sep, 13 | 77,753,665 | 3.46% |
| 30 Jun, 13 | 75,152,814 | 60.74% |
| 31 Mar, 13 | 46,753,529 | 7.19% |
| 31 Dec, 12 | 43,618,754 | 1.03% |
| 30 Sep, 12 | 43,172,735 | -23.13% |
| 30 Jun, 12 | 56,162,408 | 13.27% |
| 31 Mar, 12 | 49,581,533 | 10.70% |
| 31 Dec, 11 | 44,788,863 | 189.53% |
| 30 Sep, 11 | 15,469,583 | -26.99% |
| 30 Jun, 11 | 21,187,739 | 7.49% |
| 31 Mar, 11 | 19,710,859 | 37.63% |
| 31 Dec, 10 | 14,321,920 | -10.25% |
| 30 Sep, 10 | 15,957,522 | 11.12% |
| 30 Jun, 10 | 14,360,608 | 7.39% |
| 31 Mar, 10 | 13,372,748 | -5.44% |
| 31 Dec, 09 | 14,142,090 | 96.29% |
| 30 Sep, 09 | 7,204,665 | -50.65% |
| 30 Jun, 09 | 14,599,640 | 25.57% |
| 31 Mar, 09 | 11,627,029 | -19.84% |
| 31 Dec, 08 | 14,505,355 | 92.08% |
| 30 Sep, 08 | 7,551,757 | -40.13% |
| 30 Jun, 08 | 12,612,881 | 31.35% |
| 31 Mar, 08 | 9,602,709 | 20.10% |
| 31 Dec, 07 | 7,995,419 | 10.66% |
| 30 Sep, 07 | 7,225,497 | 125.24% |
| 30 Jun, 07 | 3,207,881 | -52.17% |
| 31 Mar, 07 | 6,706,500 | -15.05% |
| 31 Dec, 06 | 7,894,457 | 14.56% |
| 30 Sep, 06 | 6,891,000 | 4.23% |
| 30 Jun, 06 | 6,611,300 | -0.99% |
| 31 Mar, 06 | 6,677,400 | 317.39% |
| 31 Dec, 05 | 1,599,800 | 112.51% |
| 30 Sep, 05 | 752,800 | -81.35% |
| 30 Jun, 05 | 4,035,800 | 0.92% |
| 31 Mar, 05 | 3,999,000 | 11.02% |
| 31 Dec, 04 | 3,602,100 | - |
Halozyme Therapeutics (HALO) has 122.05M shares outstanding as of 31 Mar 24, down -1.69% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 94.57% | 1.07% |
| 31 Dec, 23 | 94.07% | 1.11% |
| 30 Sep, 23 | 92.17% | 1.13% |
| 30 Jun, 23 | 90.23% | 1.08% |
| 31 Mar, 23 | 91.52% | 1.01% |
| 31 Dec, 22 | 95.05% | 1.04% |
| 30 Sep, 22 | 95.78% | 1.13% |
| 30 Jun, 22 | 92.01% | 1.09% |
| 31 Mar, 22 | 91.72% | 1.12% |
| 31 Dec, 21 | 90.55% | 1.11% |
| 30 Sep, 21 | 90.43% | 1.11% |
| 30 Jun, 21 | 90.30% | 1.00% |
| 31 Mar, 21 | 95.22% | 0.94% |
| 31 Dec, 20 | 100.82% | 1.05% |
| 30 Sep, 20 | 97.98% | 0.99% |
| 30 Jun, 20 | 99.34% | 1.10% |
| 31 Mar, 20 | 95.16% | 1.22% |
| 31 Dec, 19 | 88.19% | 1.18% |
| 30 Sep, 19 | 86.39% | 1.22% |
| 30 Jun, 19 | 84.11% | 1.20% |
| 31 Mar, 19 | 83.57% | 1.18% |
| 31 Dec, 18 | 84.16% | 1.16% |
| 30 Sep, 18 | 85.33% | 1.17% |
| 30 Jun, 18 | 85.24% | 1.14% |
| 31 Mar, 18 | 86.41% | 1.16% |
| 31 Dec, 17 | 86.16% | 1.16% |
| 30 Sep, 17 | 86.03% | 1.04% |
| 30 Jun, 17 | 91.00% | 1.13% |
| 31 Mar, 17 | 89.58% | 1.20% |
| 31 Dec, 16 | 86.48% | 1.26% |
| 30 Sep, 16 | 82.70% | 1.23% |
| 30 Jun, 16 | 82.12% | 1.27% |
| 31 Mar, 16 | 80.43% | 1.33% |
| 31 Dec, 15 | 77.64% | 1.10% |
| 30 Sep, 15 | 83.96% | 1.41% |
| 30 Jun, 15 | 77.21% | 1.37% |
| 31 Mar, 15 | 75.13% | 1.39% |
| 31 Dec, 14 | 73.51% | 1.43% |
| 30 Sep, 14 | 71.68% | 1.50% |
| 30 Jun, 14 | 69.20% | 1.33% |
| 31 Mar, 14 | 72.10% | 1.47% |
| 31 Dec, 13 | 70.11% | 1.47% |
| 30 Sep, 13 | 68.95% | 1.54% |
| 30 Jun, 13 | 66.81% | 3.86% |
| 31 Mar, 13 | 41.59% | 2.70% |
| 31 Dec, 12 | 39.27% | 2.66% |
| 30 Sep, 12 | 38.44% | 1.53% |
| 30 Jun, 12 | 50.12% | 2.36% |
| 31 Mar, 12 | 46.08% | 2.66% |
| 31 Dec, 11 | 41.63% | 18.54% |
| 30 Sep, 11 | 14.99% | 3.52% |
| 30 Jun, 11 | 20.64% | 5.41% |
| 31 Mar, 11 | 19.53% | 8.48% |
| 31 Dec, 10 | 15.18% | 5.23% |
| 30 Sep, 10 | 17.04% | 6.96% |
| 30 Jun, 10 | 15.65% | 7.34% |
| 31 Mar, 10 | 14.60% | 6.13% |
| 31 Dec, 09 | 15.44% | 23.86% |
| 30 Sep, 09 | 8.04% | 2.60% |
| 30 Jun, 09 | 17.59% | 8.84% |
| 31 Mar, 09 | 14.11% | 4.27% |
| 31 Dec, 08 | 18.17% | 20.54% |
| 30 Sep, 08 | 9.41% | 3.73% |
| 30 Jun, 08 | 15.87% | 10.55% |
| 31 Mar, 08 | 12.26% | 10.60% |
| 31 Dec, 07 | 10.76% | 12.06% |
| 30 Sep, 07 | 9.44% | 49.20% |
| 30 Jun, 07 | 4.38% | 4.77% |
| 31 Mar, 07 | 9.58% | 7.53% |
| 31 Dec, 06 | 11.28% | 9.35% |
| 30 Sep, 06 | 10.98% | 9.61% |
| 30 Jun, 06 | 10.69% | 8.76% |
| 31 Mar, 06 | 11.04% | 157.73% |
| 31 Dec, 05 | 2.65% | 116.64% |
| 30 Sep, 05 | 1.51% | 2.31% |
| 30 Jun, 05 | 8.08% | 12.42% |
| 31 Mar, 05 | 8.07% | 15.28% |
| 31 Dec, 04 | 7.27% | - |
As of 31 Mar 24, Halozyme Therapeutics is held by 94.57% institutional shareholders, representing a 1.07% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 215 | 0.94% |
| 31 Dec, 23 | 213 | 18.33% |
| 30 Sep, 23 | 180 | - |
| 30 Jun, 23 | 180 | -4.26% |
| 31 Mar, 23 | 188 | -10.90% |
| 31 Dec, 22 | 211 | 15.93% |
| 30 Sep, 22 | 182 | -13.33% |
| 30 Jun, 22 | 210 | 48.94% |
| 31 Mar, 22 | 141 | -13.50% |
| 31 Dec, 21 | 163 | -9.94% |
| 30 Sep, 21 | 181 | 17.53% |
| 30 Jun, 21 | 154 | -8.88% |
| 31 Mar, 21 | 169 | -15.08% |
| 31 Dec, 20 | 199 | 57.94% |
| 30 Sep, 20 | 126 | -22.70% |
| 30 Jun, 20 | 163 | 75.27% |
| 31 Mar, 20 | 93 | -25.00% |
| 31 Dec, 19 | 124 | 30.53% |
| 30 Sep, 19 | 95 | -12.04% |
| 30 Jun, 19 | 108 | 18.68% |
| 31 Mar, 19 | 91 | -6.19% |
| 31 Dec, 18 | 97 | 16.87% |
| 30 Sep, 18 | 83 | -3.49% |
| 30 Jun, 18 | 86 | -21.10% |
| 31 Mar, 18 | 109 | -4.39% |
| 31 Dec, 17 | 114 | 31.03% |
| 30 Sep, 17 | 87 | -18.69% |
| 30 Jun, 17 | 107 | 57.35% |
| 31 Mar, 17 | 68 | -23.60% |
| 31 Dec, 16 | 89 | 20.27% |
| 30 Sep, 16 | 74 | -3.90% |
| 30 Jun, 16 | 77 | -21.43% |
| 31 Mar, 16 | 98 | 22.50% |
| 31 Dec, 15 | 80 | -22.33% |
| 30 Sep, 15 | 103 | 27.16% |
| 30 Jun, 15 | 81 | -2.41% |
| 31 Mar, 15 | 83 | 16.90% |
| 31 Dec, 14 | 71 | 16.39% |
| 30 Sep, 14 | 61 | -16.44% |
| 30 Jun, 14 | 73 | -10.98% |
| 31 Mar, 14 | 82 | 28.13% |
| 31 Dec, 13 | 64 | 10.34% |
| 30 Sep, 13 | 58 | -30.12% |
| 30 Jun, 13 | 83 | 137.14% |
| 31 Mar, 13 | 35 | 29.63% |
| 31 Dec, 12 | 27 | -3.57% |
| 30 Sep, 12 | 28 | -15.15% |
| 30 Jun, 12 | 33 | -2.94% |
| 31 Mar, 12 | 34 | -12.82% |
| 31 Dec, 11 | 39 | 50.00% |
| 30 Sep, 11 | 26 | 8.33% |
| 30 Jun, 11 | 24 | -7.69% |
| 31 Mar, 11 | 26 | 36.84% |
| 31 Dec, 10 | 19 | 18.75% |
| 30 Sep, 10 | 16 | -5.88% |
| 30 Jun, 10 | 17 | 13.33% |
| 31 Mar, 10 | 15 | -16.67% |
| 31 Dec, 09 | 18 | 63.64% |
| 30 Sep, 09 | 11 | -38.89% |
| 30 Jun, 09 | 18 | 38.46% |
| 31 Mar, 09 | 13 | -27.78% |
| 31 Dec, 08 | 18 | 20.00% |
| 30 Sep, 08 | 15 | 7.14% |
| 30 Jun, 08 | 14 | 55.56% |
| 31 Mar, 08 | 9 | 12.50% |
| 31 Dec, 07 | 8 | - |
| 30 Sep, 07 | 8 | -42.86% |
| 30 Jun, 07 | 14 | 75.00% |
| 31 Mar, 07 | 8 | 100.00% |
| 31 Dec, 06 | 4 | 33.33% |
| 30 Sep, 06 | 3 | - |
| 30 Jun, 06 | - | -100.00% |
| 31 Mar, 06 | 3 | - |
| 31 Dec, 05 | 3 | 200.00% |
| 30 Sep, 05 | 1 | - |
| 30 Jun, 05 | 1 | -50.00% |
| 31 Mar, 05 | 2 | - |
| 31 Dec, 04 | 2 | - |
215 institutional shareholders have increased their position in HALO stock as of 31 Mar 24 compared to 213 in the previous quarter (a 0.94% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 139 | -2.11% |
| 31 Dec, 23 | 142 | -1.39% |
| 30 Sep, 23 | 144 | 9.92% |
| 30 Jun, 23 | 131 | -13.82% |
| 31 Mar, 23 | 152 | -13.14% |
| 31 Dec, 22 | 175 | 44.63% |
| 30 Sep, 22 | 121 | 8.04% |
| 30 Jun, 22 | 112 | -9.68% |
| 31 Mar, 22 | 124 | 6.90% |
| 31 Dec, 21 | 116 | 24.73% |
| 30 Sep, 21 | 93 | -13.08% |
| 30 Jun, 21 | 107 | -17.69% |
| 31 Mar, 21 | 130 | 21.50% |
| 31 Dec, 20 | 107 | 8.08% |
| 30 Sep, 20 | 99 | 39.44% |
| 30 Jun, 20 | 71 | -16.47% |
| 31 Mar, 20 | 85 | 30.77% |
| 31 Dec, 19 | 65 | -8.45% |
| 30 Sep, 19 | 71 | 18.33% |
| 30 Jun, 19 | 60 | -3.23% |
| 31 Mar, 19 | 62 | 8.77% |
| 31 Dec, 18 | 57 | -10.94% |
| 30 Sep, 18 | 64 | -14.67% |
| 30 Jun, 18 | 75 | 15.38% |
| 31 Mar, 18 | 65 | 14.04% |
| 31 Dec, 17 | 57 | 14.00% |
| 30 Sep, 17 | 50 | 25.00% |
| 30 Jun, 17 | 40 | -35.48% |
| 31 Mar, 17 | 62 | 29.17% |
| 31 Dec, 16 | 48 | -5.88% |
| 30 Sep, 16 | 51 | -3.77% |
| 30 Jun, 16 | 53 | 35.90% |
| 31 Mar, 16 | 39 | -35.00% |
| 31 Dec, 15 | 60 | 15.38% |
| 30 Sep, 15 | 52 | -7.14% |
| 30 Jun, 15 | 56 | 43.59% |
| 31 Mar, 15 | 39 | 11.43% |
| 31 Dec, 14 | 35 | 2.94% |
| 30 Sep, 14 | 34 | -15.00% |
| 30 Jun, 14 | 40 | 21.21% |
| 31 Mar, 14 | 33 | -13.16% |
| 31 Dec, 13 | 38 | 15.15% |
| 30 Sep, 13 | 33 | 106.25% |
| 30 Jun, 13 | 16 | 14.29% |
| 31 Mar, 13 | 14 | -17.65% |
| 31 Dec, 12 | 17 | 41.67% |
| 30 Sep, 12 | 12 | -14.29% |
| 30 Jun, 12 | 14 | -12.50% |
| 31 Mar, 12 | 16 | 60.00% |
| 31 Dec, 11 | 10 | 25.00% |
| 30 Sep, 11 | 8 | 60.00% |
| 30 Jun, 11 | 5 | -16.67% |
| 31 Mar, 11 | 6 | -33.33% |
| 31 Dec, 10 | 9 | -10.00% |
| 30 Sep, 10 | 10 | 11.11% |
| 30 Jun, 10 | 9 | - |
| 31 Mar, 10 | 9 | 125.00% |
| 31 Dec, 09 | 4 | - |
| 30 Sep, 09 | 4 | -50.00% |
| 30 Jun, 09 | 8 | 300.00% |
| 31 Mar, 09 | 2 | -50.00% |
| 31 Dec, 08 | 4 | 100.00% |
| 30 Sep, 08 | 2 | 100.00% |
| 30 Jun, 08 | 1 | -66.67% |
| 31 Mar, 08 | 3 | -40.00% |
| 31 Dec, 07 | 5 | -28.57% |
| 30 Sep, 07 | 7 | 250.00% |
| 30 Jun, 07 | 2 | -33.33% |
| 31 Mar, 07 | 3 | 50.00% |
| 31 Dec, 06 | 2 | - |
| 30 Sep, 06 | - | -100.00% |
| 30 Jun, 06 | 3 | 50.00% |
| 31 Mar, 06 | 2 | - |
| 31 Dec, 05 | - | -100.00% |
| 30 Sep, 05 | 1 | - |
| 30 Jun, 05 | - | - |
| 31 Mar, 05 | - | - |
| 31 Dec, 04 | - | - |
139 institutional shareholders have reduced their position in HALO stock as of 31 Mar 24 compared to 142 in the previous quarter (a -2.11% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 413 | -0.96% | 122,049,630 | -1.69% | 94.57% | 1.07% | 215 | 0.94% | 139 | -2.11% |
| 31 Dec, 23 | 417 | 5.30% | 124,144,499 | 2.24% | 94.07% | 1.11% | 213 | 18.33% | 142 | -1.39% |
| 30 Sep, 23 | 396 | 5.04% | 121,421,868 | -0.34% | 92.17% | 1.13% | 180 | - | 144 | 9.92% |
| 30 Jun, 23 | 377 | -2.58% | 121,836,738 | -1.41% | 90.23% | 1.08% | 180 | -4.26% | 131 | -13.82% |
| 31 Mar, 23 | 387 | -10.83% | 123,575,162 | -3.90% | 91.52% | 1.01% | 188 | -10.90% | 152 | -13.14% |
| 31 Dec, 22 | 434 | 22.60% | 128,590,575 | -1.66% | 95.05% | 1.04% | 211 | 15.93% | 175 | 44.63% |
| 30 Sep, 22 | 354 | -3.80% | 130,764,721 | 3.03% | 95.78% | 1.13% | 182 | -13.33% | 121 | 8.04% |
| 30 Jun, 22 | 368 | 16.09% | 126,920,661 | 0.52% | 92.01% | 1.09% | 210 | 48.94% | 112 | -9.68% |
| 31 Mar, 22 | 317 | -3.06% | 126,259,874 | -0.86% | 91.72% | 1.12% | 141 | -13.50% | 124 | 6.90% |
| 31 Dec, 21 | 327 | 1.24% | 127,358,350 | -0.83% | 90.55% | 1.11% | 163 | -9.94% | 116 | 24.73% |
| 30 Sep, 21 | 323 | 1.25% | 128,425,909 | -0.18% | 90.43% | 1.11% | 181 | 17.53% | 93 | -13.08% |
| 30 Jun, 21 | 319 | -6.45% | 128,660,532 | -2.06% | 90.30% | 1.00% | 154 | -8.88% | 107 | -17.69% |
| 31 Mar, 21 | 341 | -0.87% | 131,362,215 | -3.56% | 95.22% | 0.94% | 169 | -15.08% | 130 | 21.50% |
| 31 Dec, 20 | 344 | 22.86% | 136,209,225 | 1.79% | 100.82% | 1.05% | 199 | 57.94% | 107 | 8.08% |
| 30 Sep, 20 | 280 | 1.82% | 133,814,748 | -0.90% | 97.98% | 0.99% | 126 | -22.70% | 99 | 39.44% |
| 30 Jun, 20 | 275 | 25.57% | 135,034,640 | 3.44% | 99.34% | 1.10% | 163 | 75.27% | 71 | -16.47% |
| 31 Mar, 20 | 219 | -7.20% | 130,539,846 | 2.56% | 95.16% | 1.22% | 93 | -25.00% | 85 | 30.77% |
| 31 Dec, 19 | 236 | 3.96% | 127,282,794 | 0.81% | 88.19% | 1.18% | 124 | 30.53% | 65 | -8.45% |
| 30 Sep, 19 | 227 | 5.58% | 126,253,902 | 3.23% | 86.39% | 1.22% | 95 | -12.04% | 71 | 18.33% |
| 30 Jun, 19 | 215 | 2.87% | 122,308,271 | 1.11% | 84.11% | 1.20% | 108 | 18.68% | 60 | -3.23% |
| 31 Mar, 19 | 209 | 3.98% | 120,966,485 | 0.10% | 83.57% | 1.18% | 91 | -6.19% | 62 | 8.77% |
| 31 Dec, 18 | 201 | 0.50% | 120,846,652 | -1.62% | 84.16% | 1.16% | 97 | 16.87% | 57 | -10.94% |
| 30 Sep, 18 | 200 | -1.96% | 122,836,446 | 0.37% | 85.33% | 1.17% | 83 | -3.49% | 64 | -14.67% |
| 30 Jun, 18 | 204 | -8.52% | 122,382,772 | -0.72% | 85.24% | 1.14% | 86 | -21.10% | 75 | 15.38% |
| 31 Mar, 18 | 223 | 4.69% | 123,274,827 | 0.96% | 86.41% | 1.16% | 109 | -4.39% | 65 | 14.04% |
| 31 Dec, 17 | 213 | 18.99% | 122,106,973 | 0.53% | 86.16% | 1.16% | 114 | 31.03% | 57 | 14.00% |
| 30 Sep, 17 | 179 | -1.65% | 121,459,384 | -0.41% | 86.03% | 1.04% | 87 | -18.69% | 50 | 25.00% |
| 30 Jun, 17 | 182 | 3.41% | 121,957,325 | 5.85% | 91.00% | 1.13% | 107 | 57.35% | 40 | -35.48% |
| 31 Mar, 17 | 176 | -3.83% | 115,211,787 | 4.11% | 89.58% | 1.20% | 68 | -23.60% | 62 | 29.17% |
| 31 Dec, 16 | 183 | 6.40% | 110,665,110 | 4.41% | 86.48% | 1.26% | 89 | 20.27% | 48 | -5.88% |
| 30 Sep, 16 | 172 | -1.15% | 105,987,871 | 0.87% | 82.70% | 1.23% | 74 | -3.90% | 51 | -3.77% |
| 30 Jun, 16 | 174 | -0.57% | 105,077,263 | 2.37% | 82.12% | 1.27% | 77 | -21.43% | 53 | 35.90% |
| 31 Mar, 16 | 175 | -0.57% | 102,644,695 | 4.35% | 80.43% | 1.33% | 98 | 22.50% | 39 | -35.00% |
| 31 Dec, 15 | 176 | -5.38% | 98,368,871 | -7.69% | 77.64% | 1.10% | 80 | -22.33% | 60 | 15.38% |
| 30 Sep, 15 | 186 | 10.06% | 106,566,697 | 9.42% | 83.96% | 1.41% | 103 | 27.16% | 52 | -7.14% |
| 30 Jun, 15 | 169 | 19.01% | 97,395,046 | 3.46% | 77.21% | 1.37% | 81 | -2.41% | 56 | 43.59% |
| 31 Mar, 15 | 142 | 1.43% | 94,136,666 | 3.05% | 75.13% | 1.39% | 83 | 16.90% | 39 | 11.43% |
| 31 Dec, 14 | 140 | 10.24% | 91,347,642 | 2.74% | 73.51% | 1.43% | 71 | 16.39% | 35 | 2.94% |
| 30 Sep, 14 | 127 | -7.30% | 88,909,692 | 3.86% | 71.68% | 1.50% | 61 | -16.44% | 34 | -15.00% |
| 30 Jun, 14 | 137 | -2.84% | 85,607,980 | -0.17% | 69.20% | 1.33% | 73 | -10.98% | 40 | 21.21% |
| 31 Mar, 14 | 141 | 10.16% | 85,756,477 | 8.43% | 72.10% | 1.47% | 82 | 28.13% | 33 | -13.16% |
| 31 Dec, 13 | 128 | 11.30% | 79,089,063 | 1.72% | 70.11% | 1.47% | 64 | 10.34% | 38 | 15.15% |
| 30 Sep, 13 | 115 | 2.68% | 77,753,665 | 3.46% | 68.95% | 1.54% | 58 | -30.12% | 33 | 106.25% |
| 30 Jun, 13 | 112 | 107.41% | 75,152,814 | 60.74% | 66.81% | 3.86% | 83 | 137.14% | 16 | 14.29% |
| 31 Mar, 13 | 54 | 5.88% | 46,753,529 | 7.19% | 41.59% | 2.70% | 35 | 29.63% | 14 | -17.65% |
| 31 Dec, 12 | 51 | 8.51% | 43,618,754 | 1.03% | 39.27% | 2.66% | 27 | -3.57% | 17 | 41.67% |
| 30 Sep, 12 | 47 | -9.62% | 43,172,735 | -23.13% | 38.44% | 1.53% | 28 | -15.15% | 12 | -14.29% |
| 30 Jun, 12 | 52 | -8.77% | 56,162,408 | 13.27% | 50.12% | 2.36% | 33 | -2.94% | 14 | -12.50% |
| 31 Mar, 12 | 57 | 5.56% | 49,581,533 | 10.70% | 46.08% | 2.66% | 34 | -12.82% | 16 | 60.00% |
| 31 Dec, 11 | 54 | 31.71% | 44,788,863 | 189.53% | 41.63% | 18.54% | 39 | 50.00% | 10 | 25.00% |
| 30 Sep, 11 | 41 | 10.81% | 15,469,583 | -26.99% | 14.99% | 3.52% | 26 | 8.33% | 8 | 60.00% |
| 30 Jun, 11 | 37 | -5.13% | 21,187,739 | 7.49% | 20.64% | 5.41% | 24 | -7.69% | 5 | -16.67% |
| 31 Mar, 11 | 39 | 11.43% | 19,710,859 | 37.63% | 19.53% | 8.48% | 26 | 36.84% | 6 | -33.33% |
| 31 Dec, 10 | 35 | 9.38% | 14,321,920 | -10.25% | 15.18% | 5.23% | 19 | 18.75% | 9 | -10.00% |
| 30 Sep, 10 | 32 | 6.67% | 15,957,522 | 11.12% | 17.04% | 6.96% | 16 | -5.88% | 10 | 11.11% |
| 30 Jun, 10 | 30 | 7.14% | 14,360,608 | 7.39% | 15.65% | 7.34% | 17 | 13.33% | 9 | - |
| 31 Mar, 10 | 28 | -3.45% | 13,372,748 | -5.44% | 14.60% | 6.13% | 15 | -16.67% | 9 | 125.00% |
| 31 Dec, 09 | 29 | 52.63% | 14,142,090 | 96.29% | 15.44% | 23.86% | 18 | 63.64% | 4 | - |
| 30 Sep, 09 | 19 | -26.92% | 7,204,665 | -50.65% | 8.04% | 2.60% | 11 | -38.89% | 4 | -50.00% |
| 30 Jun, 09 | 26 | 44.44% | 14,599,640 | 25.57% | 17.59% | 8.84% | 18 | 38.46% | 8 | 300.00% |
| 31 Mar, 09 | 18 | -25.00% | 11,627,029 | -19.84% | 14.11% | 4.27% | 13 | -27.78% | 2 | -50.00% |
| 31 Dec, 08 | 24 | 14.29% | 14,505,355 | 92.08% | 18.17% | 20.54% | 18 | 20.00% | 4 | 100.00% |
| 30 Sep, 08 | 21 | 31.25% | 7,551,757 | -40.13% | 9.41% | 3.73% | 15 | 7.14% | 2 | 100.00% |
| 30 Jun, 08 | 16 | 6.67% | 12,612,881 | 31.35% | 15.87% | 10.55% | 14 | 55.56% | 1 | -66.67% |
| 31 Mar, 08 | 15 | -11.76% | 9,602,709 | 20.10% | 12.26% | 10.60% | 9 | 12.50% | 3 | -40.00% |
| 31 Dec, 07 | 17 | - | 7,995,419 | 10.66% | 10.76% | 12.06% | 8 | - | 5 | -28.57% |
| 30 Sep, 07 | 17 | -5.56% | 7,225,497 | 125.24% | 9.44% | 49.20% | 8 | -42.86% | 7 | 250.00% |
| 30 Jun, 07 | 18 | 63.64% | 3,207,881 | -52.17% | 4.38% | 4.77% | 14 | 75.00% | 2 | -33.33% |
| 31 Mar, 07 | 11 | 57.14% | 6,706,500 | -15.05% | 9.58% | 7.53% | 8 | 100.00% | 3 | 50.00% |
| 31 Dec, 06 | 7 | 16.67% | 7,894,457 | 14.56% | 11.28% | 9.35% | 4 | 33.33% | 2 | - |
| 30 Sep, 06 | 6 | - | 6,891,000 | 4.23% | 10.98% | 9.61% | 3 | - | - | -100.00% |
| 30 Jun, 06 | 6 | - | 6,611,300 | -0.99% | 10.69% | 8.76% | - | -100.00% | 3 | 50.00% |
| 31 Mar, 06 | 6 | 100.00% | 6,677,400 | 317.39% | 11.04% | 157.73% | 3 | - | 2 | - |
| 31 Dec, 05 | 3 | - | 1,599,800 | 112.51% | 2.65% | 116.64% | 3 | 200.00% | - | -100.00% |
| 30 Sep, 05 | 3 | - | 752,800 | -81.35% | 1.51% | 2.31% | 1 | - | 1 | - |
| 30 Jun, 05 | 3 | - | 4,035,800 | 0.92% | 8.08% | 12.42% | 1 | -50.00% | - | - |
| 31 Mar, 05 | 3 | 50.00% | 3,999,000 | 11.02% | 8.07% | 15.28% | 2 | - | - | - |
| 31 Dec, 04 | 2 | - | 3,602,100 | - | 7.27% | - | 2 | - | - | - |
Halozyme Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Halozyme Therapeutics's stock was made by LaBarre Michael J. on Apr 17 2024, selling 10,000 shares at $38.49 per share (valued at $384.89K).
Halozyme Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 1 | 4 | 25.00% |
| Q1 2024 | 32 | 45 | 71.11% |
| Q4 2023 | 6 | 13 | 46.15% |
| Q3 2023 | 9 | 29 | 31.03% |
| Q2 2023 | 18 | 4 | 450.00% |
| Q1 2023 | 26 | 53 | 49.06% |
| Q4 2022 | 2 | 23 | 8.70% |
| Q2 2022 | 7 | - | - |
| Q1 2022 | 20 | 27 | 74.07% |
| Q4 2021 | 4 | 11 | 36.36% |
| Q3 2021 | 6 | 18 | 33.33% |
| Q2 2021 | 12 | 16 | 75.00% |
| Q1 2021 | 21 | 37 | 56.76% |
| Q4 2020 | 1 | 15 | 6.67% |
| Q3 2020 | 1 | 9 | 11.11% |
| Q2 2020 | 10 | 3 | 333.33% |
| Q1 2020 | 27 | 32 | 84.38% |
| Q4 2019 | 1 | 2 | 50.00% |
| Q3 2019 | - | 3 | - |
| Q2 2019 | 12 | 6 | 200.00% |
1 total buy trades, and 4 total sell trades (buy/sell ratio of 0.25%) were made by Halozyme Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 2 | - |
| Q1 2024 | - | 6 | - |
| Q4 2023 | - | 6 | - |
| Q3 2023 | - | 14 | - |
| Q2 2023 | - | 2 | - |
| Q1 2023 | - | 19 | - |
| Q4 2022 | - | 15 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 7 | - |
| Q3 2021 | - | 11 | - |
| Q2 2021 | - | 9 | - |
| Q1 2021 | - | 12 | - |
| Q4 2020 | - | 13 | - |
| Q3 2020 | - | 5 | - |
| Q2 2020 | - | 1 | - |
| Q1 2020 | 3 | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | 1 | - |
| Q2 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Halozyme Therapeutics's stocks.
Halozyme Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| DICE | DICE Therapeutics, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| BMRN | BioMarin Pharmaceutical Inc. |
| BGNE | BeiGene, Ltd. |
| VRDN | Viridian Therapeutics, Inc. |
| INBX | Inhibrx, Inc. |
| ALNY | Alnylam Pharmaceuticals, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| LEGN | Legend Biotech Corporation |
| BPMC | Blueprint Medicines Corporation |
| LRMR | Larimar Therapeutics, Inc. |
| ALEC | Alector, Inc. |
| EXEL | Exelixis, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| INSM | Insmed Incorporated |
| PTGX | Protagonist Therapeutics, Inc. |
| CYTK | Cytokinetics, Incorporated |
| ASND | Ascendis Pharma A/S |
| RARE | Ultragenyx Pharmaceutical Inc. |
| AGIO | Agios Pharmaceuticals, Inc. |
HALO Ownership FAQ
Who Owns Halozyme Therapeutics?
Halozyme Therapeutics is owned by institutional shareholders (94.57%), insiders (1.11%), and public (4.31%). The largest institutional shareholder of Halozyme Therapeutics is BLACKROCK INC. (14.13% of total shares) and the top mutual fund owner is AMG FUNDS (3.38% of total shares).
Who are the major institutional shareholders of Halozyme Therapeutics?
Halozyme Therapeutics's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, STATE STREET CORP, SNYDER CAPITAL MANAGEMENT L P, and ARTISAN PARTNERS LIMITED PARTNERSHIP. The top five shareholders own together 35.40% of the company's share outstanding.
How many Halozyme Therapeutics shareholders are there?
As of Mar 2024, there are 413 institutional shareholders of Halozyme Therapeutics.
What percentage of Halozyme Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC owns 18.24M shares of Halozyme Therapeutics, representing 14.13% of the company's total shares outstanding, valued at $742.07M (as of Mar 2024).
What percentage of Halozyme Therapeutics is owned by VANGUARD GROUP INC?
As of Mar 2024, VANGUARD GROUP INC holds 13.05M shares of Halozyme Therapeutics (HALO), compromising 10.11% of the company, valued at $530.84M.
What percentage of Halozyme Therapeutics is owned by STATE STREET CORP?
STATE STREET CORP is the third largest holder of Halozyme Therapeutics. The company owns 6.49M of the company's shares outstanding (worth $263.9M).